289 related articles for article (PubMed ID: 34146626)
1. Dynamic nanoassemblies for imaging and therapy of neurological disorders.
Zhang L; Sun H; Zhao J; Lee J; Ee Low L; Gong L; Chen Y; Wang N; Zhu C; Lin P; Liang Z; Wei M; Ling D; Li F
Adv Drug Deliv Rev; 2021 Aug; 175():113832. PubMed ID: 34146626
[TBL] [Abstract][Full Text] [Related]
2. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases.
Zhang L; Sun H; Chen Y; Wei M; Lee J; Li F; Ling D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1696. PubMed ID: 33463089
[TBL] [Abstract][Full Text] [Related]
3. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders.
Waris A; Ali A; Khan AU; Asim M; Zamel D; Fatima K; Raziq A; Khan MA; Akbar N; Baset A; Abourehab MAS
Nanomaterials (Basel); 2022 Jun; 12(13):. PubMed ID: 35807977
[TBL] [Abstract][Full Text] [Related]
4. Advances in nanomedicines for diagnosis of central nervous system disorders.
Zhang X; Zhou J; Gu Z; Zhang H; Gong Q; Luo K
Biomaterials; 2021 Feb; 269():120492. PubMed ID: 33153757
[TBL] [Abstract][Full Text] [Related]
5. Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review.
Moradi F; Dashti N
Naunyn Schmiedebergs Arch Pharmacol; 2022 Feb; 395(2):133-148. PubMed ID: 34982185
[TBL] [Abstract][Full Text] [Related]
6. Copper: From enigma to therapeutic target for neurological disorder.
Patwa J; Flora SJS
Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):778-791. PubMed ID: 38622813
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications.
Giri PM; Banerjee A; Ghosal A; Layek B
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612804
[TBL] [Abstract][Full Text] [Related]
8. Drug targeting strategies into the brain for treating neurological diseases.
Barnabas W
J Neurosci Methods; 2019 Jan; 311():133-146. PubMed ID: 30336221
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
[TBL] [Abstract][Full Text] [Related]
10. Microenvironment-tailored nanoassemblies for the diagnosis and therapy of neurodegenerative diseases.
Low LE; Wang Q; Chen Y; Lin P; Yang S; Gong L; Lee J; Siva SP; Goh BH; Li F; Ling D
Nanoscale; 2021 Jun; 13(23):10197-10238. PubMed ID: 34027535
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.
Rhaman MM; Islam MR; Akash S; Mim M; Noor Alam M; Nepovimova E; Valis M; Kuca K; Sharma R
Front Cell Dev Biol; 2022; 10():989471. PubMed ID: 36120565
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects.
Alkahtani S; Al-Johani NS; Alarifi S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674852
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases.
Zhang Y; Yang H; Wei D; Zhang X; Wang J; Wu X; Chang J
Exploration (Beijing); 2021 Dec; 1(3):20210115. PubMed ID: 37323688
[TBL] [Abstract][Full Text] [Related]
14. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
[TBL] [Abstract][Full Text] [Related]
15. Carbon dots as versatile nanoarchitectures for the treatment of neurological disorders and their theranostic applications: A review.
Ashrafizadeh M; Mohammadinejad R; Kailasa SK; Ahmadi Z; Afshar EG; Pardakhty A
Adv Colloid Interface Sci; 2020 Apr; 278():102123. PubMed ID: 32087367
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.
Kanwar JR; Sun X; Punj V; Sriramoju B; Mohan RR; Zhou SF; Chauhan A; Kanwar RK
Nanomedicine; 2012 May; 8(4):399-414. PubMed ID: 21889479
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases.
Riccardi C; Napolitano F; Montesarchio D; Sampaolo S; Melone MAB
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834311
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle transport across the blood brain barrier.
Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
[TBL] [Abstract][Full Text] [Related]
19. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
